Home
About
Overview
Sharing Data
ORCID
Help
History (12)
Dual antimicrobial-loaded biodegradable nanoemulsions for synergistic treatment of wound biofilms.
Crossing the Age Divide: Cross-Age Collaboration Between Programs Serving Transition-Age Youth.
Correction: Difference in levels of SARS-CoV-2 S1 and S2 subunits- and nucleocapsid protein-reactive SIgM/IgM, IgG and SIgA/IgA antibodies in human milk.
Six-month treatment outcomes of cocaine-dependent patients with and without PTSD in a multisite national trial.
Precision Medicine for All?: What About Hypertrophic Cardiomyopathy?
See All 12 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Precision Medicine for All?: What About Hypertrophic Cardiomyopathy?
Maron BJ, Maron MS, Rowin EJ. Precision Medicine for All?: What About Hypertrophic Cardiomyopathy? JACC Adv. 2024 May; 3(5):100922.
View in:
PubMed
authors with profiles
Martin S Maron MD, MSPH
Barry J Maron MD
Ethan Rowin MD, MBA